Additionally, as reported, FLVCR1-AS1 is available to be performed as the prognostic or diagnostic biomarker in glioma, and its enhanced expression predicts unpleasing prognosis in glioma patients [26]. Here, FLVCR1 is linked to central nervous system cancer.